Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000369132 | SCV000340209 | uncertain significance | not provided | 2016-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000558292 | SCV000624296 | pathogenic | Primary ciliary dyskinesia | 2025-01-14 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 2677 of the DNAH5 protein (p.Arg2677Gln). This variant is present in population databases (no rsID available, gnomAD 0.005%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (PMID: 24150548). ClinVar contains an entry for this variant (Variation ID: 286676). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DNAH5 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV000558292 | SCV002681159 | likely pathogenic | Primary ciliary dyskinesia | 2016-12-27 | criteria provided, single submitter | clinical testing | The p.R2677Q variant (also known as c.8030G>A), located in coding exon 49 of the DNAH5 gene, results from a G to A substitution at nucleotide position 8030. The arginine at codon 2677 is replaced by glutamine, an amino acid with highly similar properties. This variant was detected in a homozygous individual with chronic rhinosinusitis, recurrent respiratory infections, bronchiectasis, and left-right laterality defects; her parents were confirmed heterozygous for this variant (Zhang J et al. Eur Arch Otorhinolaryngol, 2014 Jun;271:1589-94). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |
Fulgent Genetics, |
RCV001257434 | SCV005668850 | likely pathogenic | Primary ciliary dyskinesia 3 | 2024-04-16 | criteria provided, single submitter | clinical testing | |
Center for Molecular Medicine, |
RCV001257434 | SCV001433991 | likely pathogenic | Primary ciliary dyskinesia 3 | 2020-07-07 | no assertion criteria provided | clinical testing |